Men on Wegovy: how it works, what to expect, and whether it's right for you

You've looked into Wegovy, and now you're wondering whether it actually works for men the way the headlines suggest

That's a fair question. A lot of the coverage focuses on dramatic percentage figures without much nuance about sex differences, and men can find themselves reading trial data written primarily for a mixed population without a clear sense of where they fit. Here's what the evidence shows specifically.

The STEP 1 trial, published in the New England Journal of Medicine, enrolled adults with obesity or overweight plus at least one weight-related condition and ran for 68 weeks. The headline figure (roughly 15% average weight loss on semaglutide 2.4 mg) covered the full trial population. Sub-analyses consistently show that men tend to lose a slightly smaller percentage of starting body weight than women on GLP-1 medicines, but because men typically start at a higher absolute weight, the actual kilogram reduction is often comparable and in some cases larger. A man starting at 120 kg losing 12% loses more weight in real terms than a woman starting at 85 kg losing 15%.

That said, individual response varies considerably. Starting weight, diet quality, activity level, sleep, and adherence to the titration schedule all influence outcomes. The NHS semaglutide patient information page is a sensible starting point for understanding the medicine before committing to a consultation.

Before starting, it helps to get familiar with the full Wegovy menu of information we've put together, covering everything from eligibility to how the doses work. Wegovy for men is not a shortcut. The licence specifically requires it to be used alongside a reduced-calorie diet and increased physical activity. Our prescribers see this work best when those habits are treated as part of the plan, not an afterthought.

The side effects men report most often, and which ones to take seriously

Gastrointestinal effects dominate the side-effect profile: nausea, loose stools, constipation, reflux, and burping are the most common, particularly in the first few weeks of each new dose level. Most settle. A question our prescribers hear most weeks is whether men experience side effects differently from women, honestly, the pattern is similar, though some men find the GI effects more disruptive when eating habits have historically been higher in volume and processed food.

Fatigue and mild dizziness, particularly around dose increases, are also reported. There is a dedicated page covering Wegovy-related dizziness if that concern is specific to you.

The side effect that warrants urgent medical attention is severe abdominal pain that doesn't ease and radiates toward the back, with or without vomiting. This can be a sign of acute pancreatitis, which the MHRA highlighted in a January 2026 Drug Safety Update as an infrequent but serious risk with GLP-1 medicines. If that happens, stop the injection and seek emergency care. Do not wait to see if it resolves.

Other signs that need prompt review: symptoms suggesting gallbladder trouble (sharp upper-right abdominal pain, especially after eating), signs of a serious allergic reaction, or significant dehydration from prolonged vomiting. Any suspected side effects can be reported at the MHRA's Yellow Card scheme.

Wegovy is not recommended for anyone under 18, or during pregnancy. Men with a personal or family history of medullary thyroid carcinoma, MEN2, or a history of pancreatitis should discuss this with a prescriber before starting.

How men access Wegovy in the UK, and what the NHS route actually looks like right now

NHS access to semaglutide for weight management is restricted under NICE guidance (TA875) to specialist weight management services, a maximum treatment duration of two years, and fairly specific eligibility criteria including a BMI of 35 or above with at least one comorbidity. Waiting lists for those services are long in most areas. The eligibility question for men gets into this in more detail.

Private prescription is the route most men who contact us are considering. For a private prescription to be lawful, it still requires a genuine clinical consultation, no legitimate pharmacy dispenses these medicines without one. Understanding the full process of obtaining Wegovy in the UK is worth doing before you compare providers.

At nume, there are no waiting lists and no referral needed. A GPhC-registered prescriber, not a piece of software, reads your consultation the same day. Identity and current weight are verified by video. If treatment is clinically suitable and you order before noon on a weekday, the pen is dispatched the same day by tracked DPD delivery. Our pharmacy's GPhC registration is publicly verifiable at the GPhC register.

For a broader look at how semaglutide works and the full licensed context, the semaglutide information page covers the mechanism in plain terms. And if you want to explore how the benefits specific to men break down, the Wegovy benefits for men page goes deeper on the cardiovascular and metabolic picture.

If you're ready to find out whether this is clinically appropriate for you, speak to our prescribers through a free consultation, it takes a few minutes and there's no obligation to proceed.